Envoy Medical Inc (COCH) News

Envoy Medical to Host Fireside Chat Event December 7

Analyst Hosted Event to Feature Comprehensive Discussion of Envoy Medical’s Products, Interviews with Two Study...

Form 4 - Statement of changes in beneficial ownership of securities

Envoy Medical Provides Third Quarter 2023 Financial Results and Business Update

Interim Findings from Early Feasibility Trial Provide Important Learnings and Feedback Ahead of Pivotal...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Envoy Medical Announces Publication of Additional Patent for Implantable Cochlear Systems

Newly Published Patent Contemplates an Evolving Product Portfolio to Serve the Under-Penetrated Hearing Implant...

Form 8-K - Current report

Form 8-K - Current report

New Clinical Publication Reports First Three Patients in Early Feasibility Trial for Envoy Medical’s Fully Implanted Cochlear Device

Surgical Experience with Three Initial Acclaim® Patients Documents Innovation Efforts in the Growing Cochlear...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Envoy Medical Announces Settlement Contract

WHITE BEAR LAKE, Minn., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (NASDAQ: COCH), a hearing...

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities